Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Joint Pain Injections Market Growth 2022-2028

  • LP 4917734
  • 104 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Joint Pain Injections will have significant change from previous year. According to our (LP Information) latest study, the global Joint Pain Injections market size is USD million in 2022 from USD 2708.3 million in 2021, with a change of % between 2021 and 2022. The global Joint Pain Injections market size will reach USD 3858.5 million in 2028, growing at a CAGR of 5.2% over the analysis period.

The United States Joint Pain Injections market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Joint Pain Injections market, reaching US$ million by the year 2028. As for the Europe Joint Pain Injections landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Joint Pain Injections players cover Allergan, Pfizer, Sanofi, and Anika Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Joint Pain Injections market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Corticosteroid Injections

Hyaluronic Acid Injections

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Allergan

Pfizer

Sanofi

Anika Therapeutics

Ferring

Bioventus

Flexion Therapeutics

Zimmer Biomet Holdings

SEIKAGAKU CORPORATION

Chugai Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Joint Pain Injections Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Joint Pain Injections by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Joint Pain Injections by Country/Region, 2017, 2022 & 2028

2.2 Joint Pain Injections Segment by Type

2.2.1 Corticosteroid Injections

2.2.2 Hyaluronic Acid Injections

2.2.3 Others

2.3 Joint Pain Injections Sales by Type

2.3.1 Global Joint Pain Injections Sales Market Share by Type (2017-2022)

2.3.2 Global Joint Pain Injections Revenue and Market Share by Type (2017-2022)

2.3.3 Global Joint Pain Injections Sale Price by Type (2017-2022)

2.4 Joint Pain Injections Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Joint Pain Injections Sales by Application

2.5.1 Global Joint Pain Injections Sale Market Share by Application (2017-2022)

2.5.2 Global Joint Pain Injections Revenue and Market Share by Application (2017-2022)

2.5.3 Global Joint Pain Injections Sale Price by Application (2017-2022)

3 Global Joint Pain Injections by Company

3.1 Global Joint Pain Injections Breakdown Data by Company

3.1.1 Global Joint Pain Injections Annual Sales by Company (2020-2022)

3.1.2 Global Joint Pain Injections Sales Market Share by Company (2020-2022)

3.2 Global Joint Pain Injections Annual Revenue by Company (2020-2022)

3.2.1 Global Joint Pain Injections Revenue by Company (2020-2022)

3.2.2 Global Joint Pain Injections Revenue Market Share by Company (2020-2022)

3.3 Global Joint Pain Injections Sale Price by Company

3.4 Key Manufacturers Joint Pain Injections Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Joint Pain Injections Product Location Distribution

3.4.2 Players Joint Pain Injections Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Joint Pain Injections by Geographic Region

4.1 World Historic Joint Pain Injections Market Size by Geographic Region (2017-2022)

4.1.1 Global Joint Pain Injections Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Joint Pain Injections Annual Revenue by Geographic Region

4.2 World Historic Joint Pain Injections Market Size by Country/Region (2017-2022)

4.2.1 Global Joint Pain Injections Annual Sales by Country/Region (2017-2022)

4.2.2 Global Joint Pain Injections Annual Revenue by Country/Region

4.3 Americas Joint Pain Injections Sales Growth

4.4 APAC Joint Pain Injections Sales Growth

4.5 Europe Joint Pain Injections Sales Growth

4.6 Middle East & Africa Joint Pain Injections Sales Growth

5 Americas

5.1 Americas Joint Pain Injections Sales by Country

5.1.1 Americas Joint Pain Injections Sales by Country (2017-2022)

5.1.2 Americas Joint Pain Injections Revenue by Country (2017-2022)

5.2 Americas Joint Pain Injections Sales by Type

5.3 Americas Joint Pain Injections Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Joint Pain Injections Sales by Region

6.1.1 APAC Joint Pain Injections Sales by Region (2017-2022)

6.1.2 APAC Joint Pain Injections Revenue by Region (2017-2022)

6.2 APAC Joint Pain Injections Sales by Type

6.3 APAC Joint Pain Injections Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Joint Pain Injections by Country

7.1.1 Europe Joint Pain Injections Sales by Country (2017-2022)

7.1.2 Europe Joint Pain Injections Revenue by Country (2017-2022)

7.2 Europe Joint Pain Injections Sales by Type

7.3 Europe Joint Pain Injections Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Joint Pain Injections by Country

8.1.1 Middle East & Africa Joint Pain Injections Sales by Country (2017-2022)

8.1.2 Middle East & Africa Joint Pain Injections Revenue by Country (2017-2022)

8.2 Middle East & Africa Joint Pain Injections Sales by Type

8.3 Middle East & Africa Joint Pain Injections Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Joint Pain Injections

10.3 Manufacturing Process Analysis of Joint Pain Injections

10.4 Industry Chain Structure of Joint Pain Injections

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Joint Pain Injections Distributors

11.3 Joint Pain Injections Customer

12 World Forecast Review for Joint Pain Injections by Geographic Region

12.1 Global Joint Pain Injections Market Size Forecast by Region

12.1.1 Global Joint Pain Injections Forecast by Region (2023-2028)

12.1.2 Global Joint Pain Injections Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Joint Pain Injections Forecast by Type

12.7 Global Joint Pain Injections Forecast by Application

13 Key Players Analysis

13.1 Allergan

13.1.1 Allergan Company Information

13.1.2 Allergan Joint Pain Injections Product Offered

13.1.3 Allergan Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Main Business Overview

13.1.5 Allergan Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Joint Pain Injections Product Offered

13.2.3 Pfizer Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Joint Pain Injections Product Offered

13.3.3 Sanofi Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Anika Therapeutics

13.4.1 Anika Therapeutics Company Information

13.4.2 Anika Therapeutics Joint Pain Injections Product Offered

13.4.3 Anika Therapeutics Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Anika Therapeutics Main Business Overview

13.4.5 Anika Therapeutics Latest Developments

13.5 Ferring

13.5.1 Ferring Company Information

13.5.2 Ferring Joint Pain Injections Product Offered

13.5.3 Ferring Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Ferring Main Business Overview

13.5.5 Ferring Latest Developments

13.6 Bioventus

13.6.1 Bioventus Company Information

13.6.2 Bioventus Joint Pain Injections Product Offered

13.6.3 Bioventus Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bioventus Main Business Overview

13.6.5 Bioventus Latest Developments

13.7 Flexion Therapeutics

13.7.1 Flexion Therapeutics Company Information

13.7.2 Flexion Therapeutics Joint Pain Injections Product Offered

13.7.3 Flexion Therapeutics Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Flexion Therapeutics Main Business Overview

13.7.5 Flexion Therapeutics Latest Developments

13.8 Zimmer Biomet Holdings

13.8.1 Zimmer Biomet Holdings Company Information

13.8.2 Zimmer Biomet Holdings Joint Pain Injections Product Offered

13.8.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Zimmer Biomet Holdings Main Business Overview

13.8.5 Zimmer Biomet Holdings Latest Developments

13.9 SEIKAGAKU CORPORATION

13.9.1 SEIKAGAKU CORPORATION Company Information

13.9.2 SEIKAGAKU CORPORATION Joint Pain Injections Product Offered

13.9.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 SEIKAGAKU CORPORATION Main Business Overview

13.9.5 SEIKAGAKU CORPORATION Latest Developments

13.10 Chugai Pharmaceutical

13.10.1 Chugai Pharmaceutical Company Information

13.10.2 Chugai Pharmaceutical Joint Pain Injections Product Offered

13.10.3 Chugai Pharmaceutical Joint Pain Injections Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Chugai Pharmaceutical Main Business Overview

13.10.5 Chugai Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Joint Pain Injections Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Joint Pain Injections Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Corticosteroid Injections

Table 4. Major Players of Hyaluronic Acid Injections

Table 5. Major Players of Others

Table 6. Global Joint Pain Injections Sales by Type (2017-2022) & (K Units)

Table 7. Global Joint Pain Injections Sales Market Share by Type (2017-2022)

Table 8. Global Joint Pain Injections Revenue by Type (2017-2022) & ($ million)

Table 9. Global Joint Pain Injections Revenue Market Share by Type (2017-2022)

Table 10. Global Joint Pain Injections Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Joint Pain Injections Sales by Application (2017-2022) & (K Units)

Table 12. Global Joint Pain Injections Sales Market Share by Application (2017-2022)

Table 13. Global Joint Pain Injections Revenue by Application (2017-2022)

Table 14. Global Joint Pain Injections Revenue Market Share by Application (2017-2022)

Table 15. Global Joint Pain Injections Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Joint Pain Injections Sales by Company (2020-2022) & (K Units)

Table 17. Global Joint Pain Injections Sales Market Share by Company (2020-2022)

Table 18. Global Joint Pain Injections Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Joint Pain Injections Revenue Market Share by Company (2020-2022)

Table 20. Global Joint Pain Injections Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Joint Pain Injections Producing Area Distribution and Sales Area

Table 22. Players Joint Pain Injections Products Offered

Table 23. Joint Pain Injections Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Joint Pain Injections Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Joint Pain Injections Sales Market Share Geographic Region (2017-2022)

Table 28. Global Joint Pain Injections Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Joint Pain Injections Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Joint Pain Injections Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Joint Pain Injections Sales Market Share by Country/Region (2017-2022)

Table 32. Global Joint Pain Injections Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Joint Pain Injections Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Joint Pain Injections Sales by Country (2017-2022) & (K Units)

Table 35. Americas Joint Pain Injections Sales Market Share by Country (2017-2022)

Table 36. Americas Joint Pain Injections Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Joint Pain Injections Revenue Market Share by Country (2017-2022)

Table 38. Americas Joint Pain Injections Sales by Type (2017-2022) & (K Units)

Table 39. Americas Joint Pain Injections Sales Market Share by Type (2017-2022)

Table 40. Americas Joint Pain Injections Sales by Application (2017-2022) & (K Units)

Table 41. Americas Joint Pain Injections Sales Market Share by Application (2017-2022)

Table 42. APAC Joint Pain Injections Sales by Region (2017-2022) & (K Units)

Table 43. APAC Joint Pain Injections Sales Market Share by Region (2017-2022)

Table 44. APAC Joint Pain Injections Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Joint Pain Injections Revenue Market Share by Region (2017-2022)

Table 46. APAC Joint Pain Injections Sales by Type (2017-2022) & (K Units)

Table 47. APAC Joint Pain Injections Sales Market Share by Type (2017-2022)

Table 48. APAC Joint Pain Injections Sales by Application (2017-2022) & (K Units)

Table 49. APAC Joint Pain Injections Sales Market Share by Application (2017-2022)

Table 50. Europe Joint Pain Injections Sales by Country (2017-2022) & (K Units)

Table 51. Europe Joint Pain Injections Sales Market Share by Country (2017-2022)

Table 52. Europe Joint Pain Injections Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Joint Pain Injections Revenue Market Share by Country (2017-2022)

Table 54. Europe Joint Pain Injections Sales by Type (2017-2022) & (K Units)

Table 55. Europe Joint Pain Injections Sales Market Share by Type (2017-2022)

Table 56. Europe Joint Pain Injections Sales by Application (2017-2022) & (K Units)

Table 57. Europe Joint Pain Injections Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Joint Pain Injections Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Joint Pain Injections Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Joint Pain Injections Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Joint Pain Injections Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Joint Pain Injections Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Joint Pain Injections Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Joint Pain Injections Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Joint Pain Injections Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Joint Pain Injections

Table 67. Key Market Challenges & Risks of Joint Pain Injections

Table 68. Key Industry Trends of Joint Pain Injections

Table 69. Joint Pain Injections Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Joint Pain Injections Distributors List

Table 72. Joint Pain Injections Customer List

Table 73. Global Joint Pain Injections Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Joint Pain Injections Sales Market Forecast by Region

Table 75. Global Joint Pain Injections Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Joint Pain Injections Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Joint Pain Injections Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Joint Pain Injections Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Joint Pain Injections Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Joint Pain Injections Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Joint Pain Injections Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Joint Pain Injections Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Joint Pain Injections Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Joint Pain Injections Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Joint Pain Injections Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Joint Pain Injections Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Joint Pain Injections Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Joint Pain Injections Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Joint Pain Injections Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Joint Pain Injections Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Joint Pain Injections Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Joint Pain Injections Revenue Market Share Forecast by Application (2023-2028)

Table 93. Allergan Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 94. Allergan Joint Pain Injections Product Offered

Table 95. Allergan Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Allergan Main Business

Table 97. Allergan Latest Developments

Table 98. Pfizer Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 99. Pfizer Joint Pain Injections Product Offered

Table 100. Pfizer Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Pfizer Main Business

Table 102. Pfizer Latest Developments

Table 103. Sanofi Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 104. Sanofi Joint Pain Injections Product Offered

Table 105. Sanofi Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Sanofi Main Business

Table 107. Sanofi Latest Developments

Table 108. Anika Therapeutics Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 109. Anika Therapeutics Joint Pain Injections Product Offered

Table 110. Anika Therapeutics Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Anika Therapeutics Main Business

Table 112. Anika Therapeutics Latest Developments

Table 113. Ferring Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 114. Ferring Joint Pain Injections Product Offered

Table 115. Ferring Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Ferring Main Business

Table 117. Ferring Latest Developments

Table 118. Bioventus Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 119. Bioventus Joint Pain Injections Product Offered

Table 120. Bioventus Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Bioventus Main Business

Table 122. Bioventus Latest Developments

Table 123. Flexion Therapeutics Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 124. Flexion Therapeutics Joint Pain Injections Product Offered

Table 125. Flexion Therapeutics Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Flexion Therapeutics Main Business

Table 127. Flexion Therapeutics Latest Developments

Table 128. Zimmer Biomet Holdings Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 129. Zimmer Biomet Holdings Joint Pain Injections Product Offered

Table 130. Zimmer Biomet Holdings Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Zimmer Biomet Holdings Main Business

Table 132. Zimmer Biomet Holdings Latest Developments

Table 133. SEIKAGAKU CORPORATION Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 134. SEIKAGAKU CORPORATION Joint Pain Injections Product Offered

Table 135. SEIKAGAKU CORPORATION Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. SEIKAGAKU CORPORATION Main Business

Table 137. SEIKAGAKU CORPORATION Latest Developments

Table 138. Chugai Pharmaceutical Basic Information, Joint Pain Injections Manufacturing Base, Sales Area and Its Competitors

Table 139. Chugai Pharmaceutical Joint Pain Injections Product Offered

Table 140. Chugai Pharmaceutical Joint Pain Injections Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Chugai Pharmaceutical Main Business

Table 142. Chugai Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Joint Pain Injections

Figure 2. Joint Pain Injections Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Joint Pain Injections Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Joint Pain Injections Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Joint Pain Injections Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Corticosteroid Injections

Figure 10. Product Picture of Hyaluronic Acid Injections

Figure 11. Product Picture of Others

Figure 12. Global Joint Pain Injections Sales Market Share by Type in 2021

Figure 13. Global Joint Pain Injections Revenue Market Share by Type (2017-2022)

Figure 14. Joint Pain Injections Consumed in Hospital Pharmacies

Figure 15. Global Joint Pain Injections Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 16. Joint Pain Injections Consumed in Retail Pharmacies

Figure 17. Global Joint Pain Injections Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 18. Joint Pain Injections Consumed in Online Pharmacies

Figure 19. Global Joint Pain Injections Market: Online Pharmacies (2017-2022) & (K Units)

Figure 20. Global Joint Pain Injections Sales Market Share by Application (2017-2022)

Figure 21. Global Joint Pain Injections Revenue Market Share by Application in 2021

Figure 22. Joint Pain Injections Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Joint Pain Injections Revenue Market Share by Company in 2021

Figure 24. Global Joint Pain Injections Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Joint Pain Injections Revenue Market Share by Geographic Region in 2021

Figure 26. Global Joint Pain Injections Sales Market Share by Region (2017-2022)

Figure 27. Global Joint Pain Injections Revenue Market Share by Country/Region in 2021

Figure 28. Americas Joint Pain Injections Sales 2017-2022 (K Units)

Figure 29. Americas Joint Pain Injections Revenue 2017-2022 ($ Millions)

Figure 30. APAC Joint Pain Injections Sales 2017-2022 (K Units)

Figure 31. APAC Joint Pain Injections Revenue 2017-2022 ($ Millions)

Figure 32. Europe Joint Pain Injections Sales 2017-2022 (K Units)

Figure 33. Europe Joint Pain Injections Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Joint Pain Injections Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Joint Pain Injections Revenue 2017-2022 ($ Millions)

Figure 36. Americas Joint Pain Injections Sales Market Share by Country in 2021

Figure 37. Americas Joint Pain Injections Revenue Market Share by Country in 2021

Figure 38. United States Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Joint Pain Injections Sales Market Share by Region in 2021

Figure 43. APAC Joint Pain Injections Revenue Market Share by Regions in 2021

Figure 44. China Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Joint Pain Injections Sales Market Share by Country in 2021

Figure 51. Europe Joint Pain Injections Revenue Market Share by Country in 2021

Figure 52. Germany Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Joint Pain Injections Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Joint Pain Injections Revenue Market Share by Country in 2021

Figure 59. Egypt Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Joint Pain Injections Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Joint Pain Injections in 2021

Figure 65. Manufacturing Process Analysis of Joint Pain Injections

Figure 66. Industry Chain Structure of Joint Pain Injections

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390